ENLV
Enlivex Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.21
+1.17%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.28
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 25, 2026
- EPS actual
- -$0.31
- EPS estimate
- -$0.31
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -147.9%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 25, 2026 | -$0.31 | -$0.31 | In line | — |
| Mar 30, 2026 | -$0.03 | -$0.23 | Miss -666.67% | — |
| Nov 14, 2025 | -$0.12 | -$0.09 | Beat 25.00% | — |
| Aug 29, 2025 | -$0.16 | -$0.08 | Beat 50.00% | — |
| May 30, 2025 | -$0.16 | -$0.15 | Beat 6.25% | — |
| Feb 26, 2025 | -$0.16 | -$0.24 | Miss -47.75% | — |
| Nov 29, 2024 | -$0.16 | -$0.12 | Beat 25.00% | — |
| Aug 30, 2024 | -$0.22 | -$0.16 | Beat 27.27% | — |
| Jun 14, 2024 | -$0.25 | -$0.22 | Beat 12.00% | — |
| Nov 9, 2023 | -$0.32 | -$0.32 | In line | — |
| Sep 1, 2023 | -$0.43 | -$0.37 | Beat 13.95% | — |
| Apr 4, 2023 | -$0.40 | -$0.39 | Beat 2.50% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026